Associations of clinical personnel characteristics and controlled substance prescribing practices

Abstract Context Over 68,000 deaths were attributed to opioid-related overdose in 2020. Evaluative studies have shown that states that utilized Prescription Drug Monitoring Program (PDMP) systems have decreased opioid-related deaths. With the growing use of PDMPs and an ongoing opioid epidemic, determining the demographics of physicians at risk of overprescribing can elucidate prescribing practices and inform recommendations to change prescribing behaviors. Objectives This study aims to assess prescribing behaviors by physicians in 2021 based on four demographics utilizing the National Electronic Health Record System (NEHRS): physician’s age, sex, specialty, and degree (MD or Doctor of Osteopathic Medicine [DO]). Methods We performed a cross-sectional study of the 2021 NEHRS to determine the relationship between physician characteristics and PDMP use on opioid-prescribing behaviors. Differences between groups were measured via design-based chi-square tests. We constructed multivariable logistic regression models to assess the relationships, via adjusted odds ratios (AOR), between physician characteristics and alternate prescribing patterns. Results Compared to female physicians, male physicians were more likely to alter their original prescription to reduce morphine milligram equivalents (MMWs) prescribed for a patient (AOR: 1.60; CI: 1.06–2.39; p=0.02), to change to a nonopioid/nonpharmacologic option (AOR: 1.91; 95 % CI: 1.28–2.86; p=0.002), to prescribe naloxone (AOR=2.06; p=0.039), or to refer for additional treatment (AOR=2.07; CI: 1.36–3.16; p<0.001). Compared to younger physicians, those over the age of 50 were less likely to change their prescription to a nonopioid/nonpharmacologic option (AOR=0.63; CI: 0.44–0.90; p=0.01) or prescribe naloxone (AOR=0.56, CI: 0.33–0.92; p=0.02). Conclusions Our results showed a statistically significant difference between specialty category and frequency of prescribing controlled substances. After checking the PDMP, male physicians were more likely to alter their original prescription to include harm-reduction strategies. Optimizing the use of PDMP systems may serve to improve prescribing among US physicians.

[1]  Oliver T. Nguyen,et al.  Factors Associated with Prescription Drug Monitoring Program Use Among US Physicians: National Electronic Health Record Survey 2018–2019 , 2022, Journal of General Internal Medicine.

[2]  R. Tamblyn,et al.  Association of clinical competence, specialty and physician country of origin with opioid prescribing for chronic pain: a cohort study , 2021, BMJ Quality & Safety.

[3]  P. Rochon,et al.  Physician variation in opioid prescribing: the importance of sex and gender , 2021, BMJ Quality & Safety.

[4]  B. Kuehn Massive Costs of the US Opioid Epidemic in Lives and Dollars. , 2021, JAMA.

[5]  Yong-Yeol Ahn,et al.  Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018 , 2021, JAMA network open.

[6]  A. Kennedy-Hendricks,et al.  Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians. , 2020, Drug and alcohol dependence.

[7]  J. Waljee,et al.  The Opioid Epidemic. , 2020, Clinics in plastic surgery.

[8]  K. Humphreys,et al.  Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study , 2020, BMJ.

[9]  R. McLeod,et al.  Postoperative opioid-prescribing patterns among surgeons and residents at university-affiliated hospitals: a survey study , 2020, Canadian journal of surgery. Journal canadien de chirurgie.

[10]  P. Austin,et al.  Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study , 2018, PloS one.

[11]  A. Jha,et al.  Comparison of Hospital Mortality and Readmission Rates for Medicare Patients Treated by Male vs Female Physicians , 2017, JAMA internal medicine.

[12]  Linda Rasubala,et al.  Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists , 2015, PloS one.

[13]  S. Weiner,et al.  Mandatory use of prescription drug monitoring programs. , 2015, JAMA.

[14]  J. Inciardi,et al.  Prescription Drug Abuse & Diversion: Role of the Pain Clinic , 2010, Journal of drug issues.